Advertisement

Clinical Oral Investigations

, Volume 20, Issue 4, pp 675–683 | Cite as

Citrullination in the periodontium—a possible link between periodontitis and rheumatoid arthritis

  • Oliver Laugisch
  • Alicia Wong
  • Aneta Sroka
  • Tomasz Kantyka
  • Joanna Koziel
  • Klaus Neuhaus
  • Anton Sculean
  • Patrick J. Venables
  • Jan Potempa
  • Burkhard Möller
  • Sigrun EickEmail author
Original Article

Abstract

Objectives

The aim of the present study was to assess human and bacterial peptidylarginine deiminase (PAD) activity in the gingival crevicular fluid (GCF) in the context of serum levels of antibodies against citrullinated epitopes in rheumatoid arthritis and periodontitis.

Materials and methods

Human PAD and Porphyromonas gingivalis-derived enzyme (PPAD) activities were measured in the GCF of 52 rheumatoid arthritis (RA) patients (48 with periodontitis and 4 without) and 44 non-RA controls (28 with periodontitis and 16 without). Serum antibodies against citrullinated epitopes were measured by ELISA. Bacteria being associated with periodontitis were determined by nucleic-acid-based methods.

Results

Citrullination was present in 26 (50 %) RA patients and 23 (48 %) controls. PAD and PPAD activities were detected in 36 (69 %) and 30 (58 %) RA patients, respectively, and in 30 (68 %) and 21 (50 %) controls, respectively. PPAD activity was higher in RA and non-RA patients with periodontitis than in those without (p = 0.038; p = 0.004), and was detected in 35 of 59 P. gingivalis-positive samples, and in 16 of 37 P. gingivalis-negative samples in association with high antibody levels against that species.

Conclusions

PAD and PPAD activities within the periodontium are elevated in RA and non-RA patients with periodontitis. PPAD secreted by P. gingivalis residing in epithelial cells may exert its citrullinating activity in distant regions of the periodontium or even distant tissues.

Clinical relevance

In periodontitis, the citrullination of proteins/peptides by human and bacterial peptidylarginine deiminases may generate antibodies after breaching immunotolerance in susceptible individuals.

Keywords

Periodontitis Rheumatoid arthritis Citrullination Porphyromonas gingivalis Citrullinated peptide antibodies 

Notes

Acknowledgments

The authors would like to thank Marianne Weibel (Department of Periodontology, Laboratory of Oral Microbiology, School of Dental Medicine, University of Bern) for technical assistance. We are indebted to Walter Bürgin (University of Bern) for statistical advice.

Funding

The study was funded by the participating departments and a research grant of the German Society of Periodontology (DGParo/GABA), along with grants from US NIH (DE 022597), the European Commission (FP7-PEOPLE-2011-ITN-290246 “RAPID” and FP7-HEALTH-F3-2012-306029 “TRIGGER”), Polish National Centre of Science project OPUS 2012/05/B/NZ6/00581, and Polish Ministry of Science and Higher Education (project 2975/7.PR/13/2014/2). Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. Oliver Laugisch was supported by German Academic Exchange Service (grant No: 314-D/08/48763) and the German Society of Periodontology (grant for a foreign training and research grant).

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Demmer RT, Molitor JA, Jacobs Jr. DR, Michalowicz BS (2011) Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol 38:998–1006CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, Chou YJ, Lan JL, Lai KL, Lin CH, Chen DY (2013) Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 72:1206–1211CrossRefPubMedGoogle Scholar
  3. 3.
    Joseph R, Rajappan S, Nath SG, Paul BJ (2013) Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatol Int 33:103–109CrossRefPubMedGoogle Scholar
  4. 4.
    Torkzaban P, Hjiabadi T, Basiri Z, Poorolajal J (2012) Effect of rheumatoid arthritis on periodontitis: a historical cohort study. J Periodontal Implant Sci 42:67–72CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nesse W, Dijkstra PU, Abbas F, Spijkervet FK, Stijger A, Tromp JA, van Dijk JL, Vissink A (2010) Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol 81:1622–1628CrossRefPubMedGoogle Scholar
  6. 6.
    Kobayashi T, Okada M, Ito S, Kobayashi D, Ishida K, Kojima A, Narita I, Murasawa A, Yoshie H (2014) Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol 85:57–67CrossRefPubMedGoogle Scholar
  7. 7.
    Erciyas K, Sezer U, Ustun K, Pehlivan Y, Kisacik B, Senyurt SZ, Tarakcioglu M, Onat AM (2013) Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 19:394–400CrossRefPubMedGoogle Scholar
  8. 8.
    Biyikoglu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoglu E, Kinane DF (2013) Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int 33:2607–2616CrossRefPubMedGoogle Scholar
  9. 9.
    Culshaw S, McInnes IB, Liew FY (2011) What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? J Clin Periodontol 38(Suppl 11):106–113CrossRefPubMedGoogle Scholar
  10. 10.
    de Pablo P, Chapple IL, Buckley CD, Dietrich T (2009) Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 5:218–224CrossRefPubMedGoogle Scholar
  11. 11.
    Mewar D, Wilson AG (2006) Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother 60:648–655CrossRefPubMedGoogle Scholar
  12. 12.
    Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, Feldmann M, Venables PJ (2010) Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 233:34–54CrossRefPubMedGoogle Scholar
  13. 13.
    Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, Saxne T, Malmstrom V, Venables PJ (2008) Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 58:2287–2295CrossRefPubMedGoogle Scholar
  14. 14.
    Hajishengallis G, Darveau RP, Curtis MA (2012) The keystone-pathogen hypothesis. Nat Rev Microbiol 10:717–725CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Guo Y, Nguyen KA, Potempa J (2010) Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon’s knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000 54:15–44CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Potempa J, Banbula A, Travis J (2000) Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 24:153–192CrossRefPubMedGoogle Scholar
  17. 17.
    McGraw WT, Potempa J, Farley D, Travis J (1999) Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 67:3248–3256PubMedPubMedCentralGoogle Scholar
  18. 18.
    Goulas T, Mizgalska D, Garcia-Ferrer I, Kantyka T, Guevara T, Szmigielski B, Sroka A, Millan C, Uson I, Veillard F, Potempa B, Mydel P, Sola M, Potempa J, Gomis-Ruth FX (2015) Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase. Sci Rep 5:11969CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G (2004) Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 28:311–318CrossRefPubMedGoogle Scholar
  20. 20.
    Okada M, Kobayashi T, Ito S, Yokoyama T, Komatsu Y, Abe A, Murasawa A, Yoshie H (2011) Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol 82:1433–1441CrossRefPubMedGoogle Scholar
  21. 21.
    Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, Holers VM, Kuhn KA, O’Dell JR (2009) Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 9:38–42CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, Kinloch A, Culshaw S, Potempa J, Venables PJ (2010) Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 62:2662–2672CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMedGoogle Scholar
  24. 24.
    Lo Frisco C, Cutler R, Bramson JB (1993) Periodontal screening and recording: perceptions and effects on practice. J Am Dent Assoc 124(226-9):231–232Google Scholar
  25. 25.
    Guentsch A, Kramesberger M, Sroka A, Pfister W, Potempa J, Eick S (2011) Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis. J Periodontol 82:1051–1060CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Guentsch A, Ronnebeck M, Puklo M, Preshaw PM, Pfister W, Eick S (2010) Influence of serum on interaction of Porphyromonas gingivalis ATCC 33277 and Aggregatibacter actinomycetemcomitans Y4 with an epithelial cell line. J Periodontal Res 45:229–238CrossRefPubMedGoogle Scholar
  27. 27.
    Eick S, Straube A, Guentsch A, Pfister W, Jentsch H (2011) Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69:12–20CrossRefPubMedGoogle Scholar
  28. 28.
    Boyde TR, Rahmatullah M (1980) Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 107:424–431CrossRefPubMedGoogle Scholar
  29. 29.
    de Pablo P, Dietrich T, Chapple IL, Milward M, Chowdhury M, Charles PJ, Buckley CD, Venables PJ (2014) The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis 73:580–586CrossRefPubMedGoogle Scholar
  30. 30.
    Quirke AM, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, Ytterberg AJ, Zubarev RA, Potempa J, Culshaw S, Guo Y, Fisher BA, Thiele G, Mikuls TR, Venables PJ (2014) Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis 73:263–269CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, Mikuls TR, Amdur RL, Richards JS, Kerr GS (2010) Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 81:223–230CrossRefPubMedGoogle Scholar
  32. 32.
    Konig J, Holtfreter B, Kocher T (2010) Periodontal health in Europe: future trends based on treatment needs and the provision of periodontal services–position paper 1. Eur J Dent Educ 14(Suppl 1):4–24CrossRefPubMedGoogle Scholar
  33. 33.
    Lopez-Longo FJ, Sanchez-Ramon S, Carreno L (2009) The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors? Drug News Perspect 22:543–548CrossRefPubMedGoogle Scholar
  34. 34.
    Harvey GP, Fitzsimmons TR, Dhamarpatni AA, Marchant C, Haynes DR, Bartold PM (2013) Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res 48:252–261CrossRefPubMedGoogle Scholar
  35. 35.
    Potikuri D, Dannana KC, Kanchinadam S, Agrawal S, Kancharla A, Rajasekhar L, Pothuraju S, Gumdal N (2012) Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: results from a case-control study. Ann Rheum Dis 71:1541–1544PubMedGoogle Scholar
  36. 36.
    Barra L, Scinocca M, Saunders S, Bhayana R, Rohekar S, Racape M, Coles R, Cairns E, Bell DA (2013) Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum 65:1439–1447CrossRefPubMedGoogle Scholar
  37. 37.
    Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, Markt J, McGowan D, Kerr GS, Redman RS, Reimold A, Griffiths G, Beatty M, Gonzalez SM, Bergman DA, Hamilton 3rd BC, Erickson AR, Sokolove J, Robinson WH, Walker C, Chandad F, O’Dell JR (2014) Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheum 66:1090–1100CrossRefGoogle Scholar
  38. 38.
    Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56:2503–2511CrossRefPubMedGoogle Scholar
  39. 39.
    Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, Mikuls TR, Venables PJ (2008) Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 58:3009–3019CrossRefPubMedGoogle Scholar
  40. 40.
    Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791–1802CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Steinert PM, Jones JC, Goldman RD (1984) Intermediate filaments. J Cell Biol 99:22s–27sCrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Goldman RD, Cleland MM, Murthy SN, Mahammad S, Kuczmarski ER (2012) Inroads into the structure and function of intermediate filament networks. J Struct Biol 177:14–23CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Sculean A, Berakdar M, Windisch P, Remberger K, Donos N, Brecx M (2003) Immunohistochemical investigation on the pattern of vimentin expression in regenerated and intact monkey and human periodontal ligament. Arch Oral Biol 48:77–86CrossRefPubMedGoogle Scholar
  44. 44.
    Hunter N, Nicholls B, Srivastava M, Chapple CC, Zoellner HF, Gibbins JR (2001) Reactive pocket epithelium in untreated chronic periodontal disease: possible derivation from developmental remnants of the enamel organ and root sheath. J Oral Pathol Med 30:178–186CrossRefPubMedGoogle Scholar
  45. 45.
    Hidaka N, Maeda K, Kawakami C, Aono M, Okada H (1981) Fibrinolytic activity in periodontal disease. The relationship between fibrinolytic activity and severity of periodontal disease. J Periodontol 52:181–186CrossRefPubMedGoogle Scholar
  46. 46.
    Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB (2012) Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 64:3083–3094CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Smit MD, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ (2012) Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 14:R222CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S (2005) Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. Med Gen Med 7:2Google Scholar
  49. 49.
    Yoshida A, Nakano Y, Yamashita Y, Oho T, Ito H, Kondo M, Ohishi M, Koga T (2001) Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res 80:346–350CrossRefPubMedGoogle Scholar
  50. 50.
    Nesse W, Westra J, van der Wal JE, Abbas F, Nicholas AP, Vissink A, Brouwer E (2012) The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 39:599–607CrossRefPubMedGoogle Scholar
  51. 51.
    Abdullah SN, Farmer EA, Spargo L, Logan R, Gully N (2013) Porphyromonas gingivalis peptidylarginine deiminase substrate specificity. Anaerobe 23:102–108CrossRefPubMedGoogle Scholar
  52. 52.
    Pyrc K, Milewska A, Kantyka T, Sroka A, Maresz K, Koziel J, Nguyen KA, Enghild JJ, Knudsen AD, Potempa J (2013) Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect Immun 81:55–64CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J (2013) Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog 9:e1003627CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Madianos PN, Papapanou PN, Nannmark U, Dahlen G, Sandros J (1996) Porphyromonas gingivalis FDC381 multiplies and persists within human oral epithelial cells in vitro. Infect Immun 64:660–664PubMedPubMedCentralGoogle Scholar
  55. 55.
    Hayashi H, Morioka M, Ichimiya S, Yamato K, Hinode D, Nagata A, Nakamura R (1993) Participation of an arginyl residue of insulin chain B in the inhibition of hemagglutination by Porphyromonas gingivalis. Oral Microbiol Immunol 8:386–389CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Oliver Laugisch
    • 1
  • Alicia Wong
    • 2
  • Aneta Sroka
    • 2
  • Tomasz Kantyka
    • 2
    • 3
  • Joanna Koziel
    • 2
  • Klaus Neuhaus
    • 4
  • Anton Sculean
    • 1
  • Patrick J. Venables
    • 5
  • Jan Potempa
    • 2
    • 3
    • 6
  • Burkhard Möller
    • 7
  • Sigrun Eick
    • 1
    Email author
  1. 1.Department of Periodontology, School of Dental MedicineUniversity of BernBernSwitzerland
  2. 2.Department of Microbiology, Faculty of Biochemistry, Biophysics and BiotechnologyJagiellonian University in KrakowKrakowPoland
  3. 3.Malopolska Center of BiotechnologyJagiellonian UniversityKrakowPoland
  4. 4.Department of Preventive, Restorative and Pediatric Dentistry, School of Dental MedicineUniversity of BernBernSwitzerland
  5. 5.Kennedy Institute, Nuffield Dept of Orthopaedics, Rheumatology and Musculoskeletal SciencesUniversity of OxfordHeadingtonUK
  6. 6.Department of Oral Immunology and Infectious DiseasesUniversity of Louisville School of DentistryLouisvilleUSA
  7. 7.Department of Rheumatology, Clinical Immunology and AllergologyUniversity Hospital of BernBernSwitzerland

Personalised recommendations